| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/21/2002 | US6391858 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/21/2002 | US6391657 Removal of viruses from protein solutions by ultrafiltration |
| 05/21/2002 | US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 05/21/2002 | US6391612 Replicating preferential plasmids; obtain nuclelotide sequences, transform cells, allow replication, recover plasmids |
| 05/21/2002 | US6391314 Immunogenic composition comprising vector that contains and expresses in vivo in porcine host cell, nucleic acid molecule or fragment thereof encoding type ii porcine circovirus antigen and pharmaceutically acceptable vehicle or diluent |
| 05/16/2002 | WO2002039116A2 Retrovirus isolated from humans |
| 05/16/2002 | WO2002038783A1 Vector |
| 05/16/2002 | WO2002038782A2 Viral expression system |
| 05/16/2002 | WO2002038778A1 Differentiation-inducing substances |
| 05/16/2002 | WO2002038774A2 Bacterial phytases and method for producing same |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038104A2 Compositions and methods for reducing the amount of salmonella in livestock |
| 05/16/2002 | WO2002026943A3 Production of virus-like hcv particles in the cells of insects |
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2001079518A3 Codon optimisation for expression in retrovirus packaging cells |
| 05/16/2002 | WO2001039802A9 Chimeric flavivirus vaccines |
| 05/16/2002 | US20020058325 Recombinant AAV packaging systems |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058043 Attenuated human rotavirus vaccine |
| 05/16/2002 | CA2428370A1 Compositions and methods for reducing the amount of salmonella in livestock |
| 05/16/2002 | CA2428161A1 Substances causing differentiation |
| 05/15/2002 | EP1204739A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 05/15/2002 | EP1204424A1 Recombinant rsv virus expression systems and vaccines |
| 05/15/2002 | CN1348991A Rotavirus causing adult's diarrhea and its culture process |
| 05/14/2002 | US6387685 Recombinant equine herpes virus having gene 12 deleted; replication-deficient vectors for gene therapy and vaccines |
| 05/14/2002 | US6387670 Method for producing recombinant virus |
| 05/14/2002 | US6387368 Hybrid adenovirus-AAV virus and methods of use thereof |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036617A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2001098514A3 Targeting viral vectors to specific cells |
| 05/10/2002 | WO2001083711A3 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 05/10/2002 | WO2001066778A3 Production of foreign polypeptides in plants as viral coat protein fusions |
| 05/10/2002 | WO2001066715A3 Rapid generation of recombinant adenoviral vectors |
| 05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055171 Generation of preferential compounds by photoactivation of indole-3-acetic acid; obtain indole-3-acetic acid, photoactivate, recover preferential compounds |
| 05/09/2002 | US20020054885 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 05/08/2002 | EP1203824A2 Reaction-based selection for expression of and concentration of catalytic moieties |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203076A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6383806 Method for the development of an HIV vaccine |
| 05/07/2002 | US6383795 Efficient purification of adenovirus |
| 05/07/2002 | US6383794 Methods of producing high titer recombinant adeno-associated virus |
| 05/07/2002 | US6383380 Chromatography resin |
| 05/02/2002 | WO2002034893A2 Synthetic viruses and uses thereof |
| 05/02/2002 | WO2002034892A1 Modified phage, comprising a non-lytic modification and expressing a kil-gene |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2001083710A3 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001027292A3 Methods and compositions for targeting a cell |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | US20020052485 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052041 Generation of preferential viral particles; obtain aggregates, inoculate aggregates in broth, infect aggregates, culture, recover viral particles from broth |
| 05/02/2002 | US20020052040 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 05/02/2002 | US20020052015 Methuselah gene, compositions and methods of use |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051966 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 05/02/2002 | US20020051769 Gene delivery vectors and their uses |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | EP1201770A2 Oligonucleotide for highly sensitive detection of hepatitis c virus and method for detection thereof |
| 05/02/2002 | EP1201750A1 Synthetic viruses and uses thereof |
| 05/02/2002 | EP1200612A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
| 05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
| 05/01/2002 | CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
| 05/01/2002 | CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| 05/01/2002 | CN1347450A Composition for preservation of infections recombinant adenoviruses |
| 05/01/2002 | CN1346886A Spodoptera exigua Multi-nucleocapside Nucleopolyedrovirus and its bioinsecticide |
| 04/30/2002 | US6380376 Purity polypeptides |
| 04/30/2002 | US6380364 Complexing; genetic engineering |
| 04/30/2002 | US6379967 A mutant viral gene that prevents viral replication in human cells; gene therapy |
| 04/30/2002 | US6379944 A recombinant cell that is permissive for replication of a bovine adenovirus vector; for preparing viable recombinant virus vaccines; gene therapy |
| 04/30/2002 | US6379943 A method where homologous recombination in plasmids is by site specific recombination via cre recombinase, to join two noninfectious dnas to form an infectious dna molecule |
| 04/30/2002 | US6379885 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 04/30/2002 | US6379674 Use of herpes vectors for tumor therapy |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain |
| 04/25/2002 | WO2002033129A2 Nucleic acid amplification controls |
| 04/25/2002 | WO2002033098A1 Process for producing viral rna polymerase |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2001062908A3 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 04/25/2002 | WO2001060847A3 avirulent, immunogenic flavivirus chimeras |